Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Whitehawk Therapeutics (WHWK) Shares Outstanding: 2018-2023

Historic Shares Outstanding for Whitehawk Therapeutics (WHWK) over the last 5 years, with Jun 2023 value amounting to $24.5 million.

  • Whitehawk Therapeutics' Shares Outstanding rose 16.67% to $24.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $24.5 million, marking a year-over-year increase of 16.67%. This contributed to the annual value of $24.4 million for FY2022, which is 16.94% up from last year.
  • Per Whitehawk Therapeutics' latest filing, its Shares Outstanding stood at $24.5 million for Q2 2023, which was up 0.34% from $24.4 million recorded in Q1 2023.
  • In the past 5 years, Whitehawk Therapeutics' Shares Outstanding ranged from a high of $40.6 million in Q1 2019 and a low of $7,212 during Q1 2020.
  • Moreover, its 3-year median value for Shares Outstanding was $21.0 million (2022), whereas its average is $19.6 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Shares Outstanding plummeted by 99.98% in 2020, and later surged by 289,459.07% in 2021.
  • Quarterly analysis of 5 years shows Whitehawk Therapeutics' Shares Outstanding stood at $7.2 million in 2019, then remained steady at $7.2 million in 2020, then soared by 189.73% to $20.9 million in 2021, then increased by 16.94% to $24.4 million in 2022, then increased by 16.67% to $24.5 million in 2023.
  • Its Shares Outstanding was $24.5 million in Q2 2023, compared to $24.4 million in Q1 2023 and $24.4 million in Q4 2022.